- Global Pharma News & Resources

ABPI response to Government's 'vision' for UK life sciences

ABPI response to Government's 'vision' for UK life sciences 

The government has launched its 10-year strategy for the UK's life sciences sector with a plan to build on successes of COVID-19 response and accelerate delivery of innovations to patients.

The Vision outlines seven critical healthcare missions that government, industry, the NHS, academia and medical research charities will work together on at speed to solve – from cancer treatment to tackling dementia.

It comes alongside a Life Sciences Investment Programme which brings the total amount of funding available to UK’s most promising life sciences companies to £1bn.

In response, Richard Torbett, Chief Executive of the ABPI, said:

“This is an ambitious statement about how the UK can become a life sciences superpower. 

“We’ve seen just how important the partnership between industry, the government and the NHS has been to the response to the pandemic, and we need to take the same approach if we are going to make the UK a global hub for life sciences.

“By putting the NHS at the centre of the vision, we can also deliver for patients and make the UK the best place in the world to research, develop, manufacture, and use the latest medicines and vaccines.”

Editor Details

Last Updated: 13-Jul-2021